LOPE vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

LOPE

45.9
AI Score
VS
UTI Wins

UTI

47.3
AI Score

Investment Advisor Scores

LOPE

46score
Recommendation
BUY

UTI

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LOPE UTI Winner
Forward P/E 14.3472 32.3625 LOPE
PEG Ratio 0.956 2.16 LOPE
Revenue Growth 6.7% 7.2% UTI
Earnings Growth 18.2% -78.9% LOPE
Tradestie Score 45.9/100 47.3/100 UTI
Profit Margin 19.6% 3.9% LOPE
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD LOPE

Relative Price Performance (Last 90 Days)

LOPE 1M: +5.9% · 3M: -6.0% UTI 1M: -42.2% · 3M: -38.9%

Current Technical Phase

LOPE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.2 · Price: $147.46

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $22.35

Fundamentals Snapshot

Metric LOPE UTI
Market Cap
Forward P/E 13.0 30.4
Trailing P/E 17.7 39.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.2% 0.0%
EPS 8.29 0.58
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.